Vericel websites use cookies, small text files stored on your browser, to personalize your web experience and to analyze website traffic. By continuing to use this website without changing your settings, you are agreeing to our use of cookies and to our collection of information. For more information about what Vericel collects and how we use it, visit our Privacy Policy.
Timothy M. Mayleben Elected to Aastrom Biosciences' Board of Directors Ann Arbor, Michigan, June 22, 2005 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) announced today that Timothy M. Mayleben has been elected to the Company's Board of Directors. Mr. Mayleben's election became effective June 20, 2005
Aastrom Biosciences' CEO to Present at the Morgan Stanley Small Cap Executive Conference Ann Arbor, Michigan, June 10, 2005 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today announced that R. Douglas Armstrong, Ph.D., Chief Executive Officer and Chairman, will present at the Morgan Stanley Small
Aastrom Biosciences, Inc. Reports Third Quarter Fiscal Year 2005 Financial Results Ann Arbor, Michigan, May 6 , 2005 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today reported financial results for the third fiscal quarter ended March 31, 2005. The Company also reported several achievements of the
Aastrom Biosciences to Hold Investor Conference Call Tomorrow Ann Arbor, Michigan, May 5, 2005 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) announced today that it will host an investor conference call tomorrow, Friday, May 6, 2005 at 11:00 a.m. (ET). Interested parties should call (785) 832-0326,
Aastrom Biosciences to Hold Investor Conference Call Ann Arbor, Michigan, May 3, 2005 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) announced today that it will host an investor conference call on Friday, May 6, 2005 at 11:00 a.m. (ET). Aastrom's call will begin with brief presentations by R.
Aastrom Biosciences' CEO to Present at Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference Ann Arbor, Michigan, April 29, 2005 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today announced that R. Douglas Armstrong, Ph.D., Chief Executive Officer and Chairman, will present at the Rodman
-- The Following is a Statement from R. Douglas Armstrong, Ph.D., Chief Executive Officer and Chairman of Aastrom Biosciences, Inc. Regarding Recent Article in New Scientist Magazine --
